Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 95

    1.

    Econometric estimation of country-specific hospital costs.

    Adam T, Evans DB, Murray CJ.

    Cost Eff Resour Alloc. 2003 Feb 26;1(1):3.

    PMID:
    12773218
    [PubMed - as supplied by publisher]
    Free PMC Article
    2.

    Determinants of variation in the cost of inpatient stays versus outpatient visits in hospitals: a multi-country analysis.

    Adam T, Evans DB.

    Soc Sci Med. 2006 Oct;63(7):1700-10.

    PMID:
    16769168
    [PubMed - indexed for MEDLINE]
    3.

    Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.

    Garside R, Pitt M, Somerville M, Stein K, Price A, Gilbert N.

    Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. Review.

    PMID:
    16545207
    [PubMed - indexed for MEDLINE]
    Free Article
    4.

    Generalisability in economic evaluation studies in healthcare: a review and case studies.

    Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, Davies LM, Eastwood A.

    Health Technol Assess. 2004 Dec;8(49):iii-iv, 1-192. Review.

    PMID:
    15544708
    [PubMed - indexed for MEDLINE]
    Free Article
    5.

    Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

    Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

    Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.

    PMID:
    16959170
    [PubMed - indexed for MEDLINE]
    Free Article
    6.

    [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

    Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

    Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

    PMID:
    15959450
    [PubMed - indexed for MEDLINE]
    7.

    Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

    Plosker GL, Figgitt DP.

    Pharmacoeconomics. 2004;22(6):389-411. Review.

    PMID:
    15099124
    [PubMed - indexed for MEDLINE]
    8.

    Resource costing for multinational neurologic clinical trials: methods and results.

    Schulman K, Burke J, Drummond M, Davies L, Carlsson P, Gruger J, Harris A, Lucioni C, Gisbert R, Llana T, Tom E, Bloom B, Willke R, Glick H.

    Health Econ. 1998 Nov;7(7):629-38.

    PMID:
    9845256
    [PubMed - indexed for MEDLINE]
    9.

    Design and analysis of unit cost estimation studies: How many hospital diagnoses? How many countries?

    Glick HA, Orzol SM, Tooley JF, Polsky D, Mauskopf JO.

    Health Econ. 2003 Jul;12(7):517-27. Review.

    PMID:
    12825205
    [PubMed - indexed for MEDLINE]
    10.

    Estimating the resource needs of scaling-up HIV/AIDS and tuberculosis interventions in sub-Saharan Africa: a systematic review for national policy makers and planners.

    Vassall A, Compernolle P.

    Health Policy. 2006 Nov;79(1):1-15. Epub 2006 Jan 4. Review.

    PMID:
    16388874
    [PubMed - indexed for MEDLINE]
    11.

    HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries.

    Marseille E, Dandona L, Marshall N, Gaist P, Bautista-Arredondo S, Rollins B, Bertozzi SM, Coovadia J, Saba J, Lioznov D, Du Plessis JA, Krupitsky E, Stanley N, Over M, Peryshkina A, Kumar SG, Muyingo S, Pitter C, Lundberg M, Kahn JG.

    BMC Health Serv Res. 2007 Jul 12;7:108.

    PMID:
    17626616
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    Improving costing methods in multicentre economic evaluation: the use of multiple imputation for unit costs.

    Grieve R, Cairns J, Thompson SG.

    Health Econ. 2010 Aug;19(8):939-54.

    PMID:
    19688811
    [PubMed - indexed for MEDLINE]
    14.

    Cost-effectiveness of group psychotherapy for depression in Uganda.

    Siskind D, Baingana F, Kim J.

    J Ment Health Policy Econ. 2008 Sep;11(3):127-33.

    PMID:
    18806302
    [PubMed - indexed for MEDLINE]
    15.

    Cost of depression in Europe.

    Sobocki P, Jönsson B, Angst J, Rehnberg C.

    J Ment Health Policy Econ. 2006 Jun;9(2):87-98.

    PMID:
    17007486
    [PubMed - indexed for MEDLINE]
    16.

    A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

    Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

    Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.

    PMID:
    16904046
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    Variation in patient routine costliness in U.S. psychiatric facilities.

    Cromwell J, Drozd EM, Gage B, Maier J, Richter E, Goldman HH.

    J Ment Health Policy Econ. 2005 Mar;8(1):15-28.

    PMID:
    15870482
    [PubMed - indexed for MEDLINE]
    18.

    Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

    Shepherd J, Jones J, Takeda A, Davidson P, Price A.

    Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.

    PMID:
    16904047
    [PubMed - indexed for MEDLINE]
    Free Article
    19.

    Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.

    Chen YF, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor RS.

    Health Technol Assess. 2008 Apr;12(11):1-278, iii. Review.

    PMID:
    18405470
    [PubMed - indexed for MEDLINE]
    Free Article
    20.

    The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial.

    Grant A, Wileman S, Ramsay C, Bojke L, Epstein D, Sculpher M, Macran S, Kilonzo M, Vale L, Francis J, Mowat A, Krukowski Z, Heading R, Thursz M, Russell I, Campbell M; REFLUX Trial Group.

    Health Technol Assess. 2008 Sep;12(31):1-181, iii-iv.

    PMID:
    18796263
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk